JP2729244B2 - Aerosol products - Google Patents
Aerosol productsInfo
- Publication number
- JP2729244B2 JP2729244B2 JP63181754A JP18175488A JP2729244B2 JP 2729244 B2 JP2729244 B2 JP 2729244B2 JP 63181754 A JP63181754 A JP 63181754A JP 18175488 A JP18175488 A JP 18175488A JP 2729244 B2 JP2729244 B2 JP 2729244B2
- Authority
- JP
- Japan
- Prior art keywords
- aerosol
- volume
- diameter
- pressure
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000443 aerosol Substances 0.000 title claims description 63
- 239000000203 mixture Substances 0.000 claims description 26
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 21
- 238000002347 injection Methods 0.000 claims description 21
- 239000007924 injection Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000004480 active ingredient Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 235000019441 ethanol Nutrition 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 4
- 150000005846 sugar alcohols Polymers 0.000 claims description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 2
- 229940032094 squalane Drugs 0.000 claims description 2
- 239000007789 gas Substances 0.000 description 17
- 239000003915 liquefied petroleum gas Substances 0.000 description 14
- 230000002940 repellent Effects 0.000 description 12
- 239000005871 repellent Substances 0.000 description 12
- 239000007921 spray Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 239000003380 propellant Substances 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 230000001166 anti-perspirative effect Effects 0.000 description 7
- 239000003213 antiperspirant Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 239000011928 denatured alcohol Substances 0.000 description 6
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 210000001072 colon Anatomy 0.000 description 5
- 229960001673 diethyltoluamide Drugs 0.000 description 5
- 238000004880 explosion Methods 0.000 description 5
- 239000003595 mist Substances 0.000 description 5
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 238000005238 degreasing Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000000245 forearm Anatomy 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 230000037380 skin damage Effects 0.000 description 3
- 238000009834 vaporization Methods 0.000 description 3
- 230000008016 vaporization Effects 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- 102100033806 Alpha-protein kinase 3 Human genes 0.000 description 2
- 101710082399 Alpha-protein kinase 3 Proteins 0.000 description 2
- 101100160821 Bacillus subtilis (strain 168) yxdJ gene Proteins 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- -1 izobtan Natural products 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- VDLQUOJGOLARHR-UHFFFAOYSA-N 2-hydroxyacetic acid;2-hydroxybenzoic acid Chemical compound OCC(O)=O.OC(=O)C1=CC=CC=C1O VDLQUOJGOLARHR-UHFFFAOYSA-N 0.000 description 1
- 241000256173 Aedes albopictus Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000005437 stratosphere Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明はエアゾール製品に関し、さらに詳しくは、人
体用、動物用等の塗布用に用いるエアゾール製品に関す
る。Description: TECHNICAL FIELD The present invention relates to an aerosol product, and more particularly, to an aerosol product used for application to humans, animals and the like.
従来から霧状で塗布するエアゾール製品としては、フ
ロンガスを使用した制汗剤、忌避剤、消炎鎮痛剤等があ
る。また、フロンガスを使用しない上記のようなエアゾ
ール製品としては例えば特開昭54−32185号に記載され
ているようなエアゾール組成物を用いたエアゾール製品
が開発されている。Conventionally, aerosol products applied in the form of a mist include antiperspirants, repellents, anti-inflammatory analgesics and the like using Freon gas. In addition, as the aerosol product using no chlorofluorocarbon gas, for example, an aerosol product using an aerosol composition as described in JP-A-54-32185 has been developed.
しかしながら、フロンガス(クロロフルオロカーボ
ン)を噴射剤として用いるエアゾール製品はフロンガス
が大気中に放出されそれ自身が難分解性であるために成
層圏まで分解せずに徐々に拡散していきそこではじめて
光分解されて塩素を放出しオゾン層を破壊することが近
年問題視されている。したがってオゾン層を破壊しない
噴射剤を用いたエアゾール製品の開発が望まれている。
一方上記した特開昭54−32185号に記載されているよう
なフロンガスを噴射剤として用いないエアゾール製品も
開発されているが、このエアゾール製品は液化石油ガス
(以下LPGと記す)を分離させていることでLPGの気相を
内容物により多く混合させて噴射し細かい霧状の噴霧状
態を得る目的で作られており、霧が塗布面に到達する迄
に周囲に飛び散るとゆう欠点を持つと同時に可燃性液化
ガスのジメチルエーテル(以下DMEと記す)をアルコー
ル、水と一緒に用いており、このDMEが人体の皮膚等に
附着して急激に気化する際に、皮膚表面上の水分、油分
をうばい、皮膚表面が白化し凍傷を起こす一歩手前のよ
うな状態になる場合があった。However, aerosol products that use CFCs (chlorofluorocarbons) as a propellant do not decompose into the stratosphere because CFCs are released into the atmosphere and themselves are difficult to decompose. In recent years, destruction of the ozone layer by releasing chlorine has been regarded as a problem. Therefore, development of an aerosol product using a propellant that does not destroy the ozone layer is desired.
On the other hand, an aerosol product which does not use chlorofluorocarbon as a propellant as described in JP-A-54-32185 has been developed, but this aerosol product separates liquefied petroleum gas (hereinafter referred to as LPG). It is made for the purpose of obtaining a fine mist spray state by mixing and spraying the gas phase of LPG in the content more, and it has the disadvantage that the mist scatters around before reaching the application surface At the same time, flammable liquefied gas dimethyl ether (hereinafter referred to as DME) is used together with alcohol and water, and when this DME adheres to human skin and evaporates rapidly, water and oil on the skin surface are removed. In some cases, the skin surface was whitened and the skin was almost one step before frostbite.
そこで本発明者らは、エアゾール製品におけるエアゾ
ール組成物の噴射剤として、フロンガスのかわりにDME
を主成分とする可燃性ガスを使用するとともに、前記エ
アゾール組成物に引火点の高い揮散抑制剤を添加し、か
つ、前記エアゾール組成物の噴射量を所定の値に規制す
ることによって、通産省告示第557号に規定された微燃
性の要件(爆発濃度1につき0.25g以上,火炎長の長
さが25cm未満、以下、法規上の微燃性の要件という)を
満足し、比較的荒い霧状で噴射の際周囲に飛散の少ない
噴射状態を得ると共に、皮膚上に噴射した場合でもDME
の急激な気化に伴う前記皮膚の傷害の危険性を防ぎ、か
つ、皮膚表面へ有効成分の保留時間を長くすることが可
能なことを見出し、この新知見に基づいてさらに研究を
重ねた結果、本発明を完成するに致った。Therefore, the present inventors have proposed to use DME instead of Freon gas as a propellant for aerosol composition in aerosol products.
A flammable gas containing as a main component is used, and a volatilization inhibitor having a high flash point is added to the aerosol composition, and the injection amount of the aerosol composition is regulated to a predetermined value to notify the Ministry of International Trade and Industry. Satisfies the requirements for slight flammability specified in No.557 (explosion concentration: 0.25 g or more, flame length is less than 25 cm, hereinafter referred to as legally required low flammability), relatively rough fog In addition to obtaining a spray state with little scattering around when spraying in the form, DME even when spraying on the skin
To prevent the risk of skin damage due to rapid vaporization of, and to be able to prolong the retention time of the active ingredient on the skin surface, as a result of further research based on this new finding, The present invention has been completed.
そこで、本発明のエアゾール製品の特徴は、20℃にお
いて水30〜60容量%、エチルアルコールおよび/または
イソプロピルアルコール20〜60容量%、ならびに、DME
を60〜95容量%含む可燃性液化ガス11〜40容量%よりな
る成分系に、全体容量に対して有効成分0.1〜12重量%
と多価アルコール0.1〜10重量%とを添加して、均一な
溶解相となるような一液のエアゾール用組成物をエアゾ
ール用耐圧容器に充填し、単位時間当りの噴射量が25℃
で0.1〜0.5g/秒となるようなエアゾール用噴射装置を上
記耐圧容器に取り付けたことにある。Therefore, the aerosol product of the present invention is characterized in that at 20 ° C., 30 to 60% by volume of water, 20 to 60% by volume of ethyl alcohol and / or isopropyl alcohol, and DME
Of flammable liquefied gas containing 11 to 40% by volume, containing 0.1 to 12% by weight of active ingredient based on the total volume
And 0.1 to 10% by weight of a polyhydric alcohol, and a one-part aerosol composition is charged into a pressure-resistant container for aerosol so as to form a uniform dissolving phase.
The aerosol injection device having a pressure of 0.1 to 0.5 g / sec is attached to the pressure-resistant container.
なお、前記エチルアルコールは変性又は未変性のエチ
ルアルコールからなる。In addition, the said ethyl alcohol consists of denatured or undenatured ethyl alcohol.
引火点の高い揮散抑制剤としては多価アルコール等が
あるが、特に好ましいものとしてブチレングリコール、
プロピレングリコール、スクワラン、グリセリンより選
ばれる1種又はそれらの混合物を挙げることができる。Examples of the high volatilization inhibitor having a high flash point include polyhydric alcohols, and particularly preferred are butylene glycol and
One type selected from propylene glycol, squalane, and glycerin or a mixture thereof can be exemplified.
また、有効成分としては、目的とするエアゾール製品
の有効成分が用いられ、例えば忌避剤エアゾールであれ
ば忌避剤有効成分が、制汗剤エアゾールであれば制汗有
効成分が、ボディコロンエアゾールであればボディコロ
ン有効成分が、消炎鎮痛剤エアゾールであれば消炎鎮痛
剤が、皮膚炎治療薬エアゾールであれば皮膚炎治療剤
が、除菌剤エアゾールであれば除菌性有効成分が、それ
ぞれ、用いられる。As the active ingredient, the active ingredient of the target aerosol product is used.For example, if the repellent aerosol is the repellent active ingredient, if the antiperspirant aerosol is the antiperspirant active ingredient, the body colon aerosol is used. If the body colon active ingredient is an anti-inflammatory analgesic aerosol, the anti-inflammatory analgesic is used.If the dermatitis therapeutic is aerosol, the dermatitis therapeutic is used. Can be
そして、前記忌避剤有効成分としてジエチルトルアミ
ドと揮散抑制剤の例えばブチレングリコールを併用して
用いる場合は、皮膚表面に内容物を塗布した時ジエチル
トルアミドを皮膚表面上に充分保留し忌避効果を長時間
持続することができるのである。When diethyltoluamide and a volatilization inhibitor such as butylene glycol are used in combination as the repellent active ingredient, when the contents are applied to the skin surface, the diethyltoluamide is sufficiently retained on the skin surface to prevent the repellent effect. It can last for a long time.
単位時間当りの噴射量、0.1〜0.5g/秒は、製品の塗布
面での液たれを防ぐと共に、法規上の微燃性の要件を満
足させるために必要な条件である。The injection amount per unit time, 0.1 to 0.5 g / sec, is a necessary condition for preventing the liquid from dripping on the coated surface of the product and satisfying the requirement of the low flammability in the regulation.
本発明に用いられる水は30容量%未満であると法規上
の微燃性の要件を満足することがむつかしく、60容量%
を超えると油溶性有効成分の溶解に不適である。また、
エチルアルコールおよび/またはイソプロピルアルコー
ル(以下アルコールと記す)は20容量%未満であると油
溶性有効成分の溶解に不適であり60容量%を超えると法
規上の微燃性の要件を満足しなくなる。可燃性液化ガス
は10容量%未満であると法規上の微燃性の要件は満足す
るが内容物の全量噴射に支障をきたす。また40容量%を
超える場合は法規上の微燃性の要件を満足させることが
むつかしい。可燃性液化ガスとしてはDMEを主成分とす
るものを使用することができる。そして、水を比較的多
く使用するためにDMEが多い混合ガスとなり通常は、DME
60〜95容量%に対しLPG5〜40容量%で用いることが望ま
しい。また前記LPGについては通常のプロパン、イゾブ
タン、ノルマルブタンを単独もしくは混合して用いるこ
とができるが、望ましくは、製品内圧を調整するために
20℃の圧力が、ゲージ圧で1.5〜5.0kg/cm2程度のLPGを
用いる方が良い。そして有効成分としては上記した水、
アルコール、可燃性液化ガスの成分系に可溶のものであ
ればさしつかえないが、一般にたとえば制汗剤、忌避
剤、消炎鎮痛剤等人体用塗布剤に用いる有効成分はアル
コールに可溶であるが水には不溶であるというものが多
く、有効成分の量が12重量%を超えると上記成分系に溶
解しなくなり、不適当であり、また0.1重量%以下では
その薬効を発揮できない。さらにまた引火点の高い揮散
抑制剤を用いるのは、既述のように、DMEの急激な気化
に伴う皮膚の傷害の危険性を防ぎ、かつ、皮膚表面へ有
効成分の保留時間を長くするためであり、0.1重量%未
満では前述の効果に乏しく、また10重量%を超えると使
用したときベタつき感が生じるのでよくない。望しくは
2〜10重量%の範囲で用いるとよい。次に単位時間当り
の噴射量が0.1g/秒未満では、使用感が悪く、0.5g/秒以
上では、法規上の微燃性の要件を満足することが困難で
あるばかりでなく内容物を皮膚上に塗布した場合、液ダ
レを起こし使用感が不良となるためである。噴射装置と
しては一般的な噴射装置を用いることができる流量をお
さえる必要上、ステム穴径は0.25φ〜0.4φmm、ハウジ
ングベーパータップの穴径は025φ〜0.4φmm、同下穴径
は0.4φ〜0.8φmmの組合せでステム穴径≦ベーパータッ
プ穴径<下穴径で上記範囲内で用いると良い。ステム穴
径はもっとも内容物の流量規制に大きく影響し0.4φmm
を超えると法規上の微燃性の要件を満足しない。また0.
25φmm未満のものは成型品、ドリル加工品とも作りにく
く一般的ではない。ハウジングペーパータップの穴径は
0.25φmm未満はステム穴径同様一般的でなく、0.4φmm
を超えると下穴との組合せの関係上内容物を噴射する際
可燃性液化ガスの気相を多く取り込みすぎて霧の状態が
細かくなりすぎると共に断続的な噴射状態(息つき噴
射)が起こる。ハウジング下穴径はステム穴径に次いで
流量規制に大きく影響する部所であり0.8φmmを超える
と流量即ち単位時間の噴射量が多くなりすぎて法規上の
微燃性の要件を満足しない。また0.4φmm未満の場合は
ベーパータップ穴径を大きくしすぎた場合と同様の状態
となりよくない。If the amount of water used in the present invention is less than 30% by volume, it is difficult to satisfy the legally required flammability requirement.
If it exceeds, it is not suitable for dissolving the oil-soluble active ingredient. Also,
If the content of ethyl alcohol and / or isopropyl alcohol (hereinafter referred to as alcohol) is less than 20% by volume, it is unsuitable for dissolving the oil-soluble active ingredient, and if it exceeds 60% by volume, the requirement for legally low flammability is not satisfied. If the amount of the flammable liquefied gas is less than 10% by volume, the requirement for flammability in the law is satisfied, but the injection of the entire contents is hindered. On the other hand, when the content exceeds 40% by volume, it is difficult to satisfy the requirement for slight flammability in regulations. As the combustible liquefied gas, a gas containing DME as a main component can be used. Then, since a relatively large amount of water is used, a mixed gas containing a large amount of DME is formed.
It is desirable to use LPG at 5 to 40% by volume with respect to 60 to 95% by volume. Further, for the LPG, ordinary propane, izobtan, normal butane can be used alone or in combination, but preferably, in order to adjust the product internal pressure.
It is better to use LPG at a pressure of 20 ° C. and a gauge pressure of about 1.5 to 5.0 kg / cm 2 . And the above-mentioned water as an active ingredient,
Alcohol and combustible liquefied gas can be used as long as they are soluble in the component system, but in general, for example, active ingredients used for human body application such as antiperspirants, repellents, anti-inflammatory analgesics are soluble in alcohol. Water is often insoluble in water, and when the amount of the active ingredient exceeds 12% by weight, the active ingredient does not dissolve in the above-mentioned component system and is unsuitable. When the amount is less than 0.1% by weight, the medicinal effect cannot be exhibited. Furthermore, the use of a volatilization inhibitor having a high flash point, as described above, prevents the risk of skin damage due to rapid vaporization of DME, and prolongs the retention time of the active ingredient on the skin surface. If it is less than 0.1% by weight, the above-mentioned effects are poor, and if it exceeds 10% by weight, stickiness is produced when used, which is not good. Preferably, it is used in the range of 2 to 10% by weight. Next, if the injection amount per unit time is less than 0.1 g / sec, the feeling of use is poor, and if it is 0.5 g / sec or more, it is difficult not only to satisfy the requirements for legally low flammability but also to remove the contents. This is because when applied on the skin, liquid dripping occurs and the feeling of use becomes poor. As the injection device, it is necessary to control the flow rate that can use a general injection device, the stem hole diameter is 0.25 φ ~ 0.4 φ mm, the hole diameter of the housing vapor tap is 025 φ ~ 0.4 φ mm, and the lower hole diameter is 0.4 φ ~ A combination of 0.8 mm and a hole diameter of stem ≤ vapor tap hole diameter <pilot hole diameter should be used within the above range. The stem hole diameter has the largest effect on the flow rate regulation of the contents, and is 0.4 mm
If it exceeds, it does not satisfy the requirement for slight flammability in regulation. Also 0.
Those with a diameter of less than 25 mm are difficult to make for both molded and drilled products and are not common. The hole diameter of the housing paper tap is
Less than 0.25φmm is not as common as stem hole diameter, 0.4φmm
If the pressure exceeds the limit, the combustible liquefied gas is taken in too much gas phase when injecting the contents due to the combination with the pilot hole, so that the state of the mist becomes too fine and an intermittent injection state (breathing injection) occurs. The pilot hole diameter of the housing is the second most important factor after the stem hole diameter, and if the diameter exceeds 0.8 mm, the flow rate, that is, the injection amount per unit time becomes too large, and does not satisfy the legally required low flammability. On the other hand, when the diameter is less than 0.4 mm, the same state as when the diameter of the vapor tap hole is too large is not good.
次に上記したような順位で穴径を設定するのは、ステ
ム穴径が他に較べ大きい場合は流量規制に効果がなく、
ベーパータップ穴径と下穴径でもベーパータップの穴径
が大きいと上記したような息付き噴射が起こってよくな
いからである。Next, setting the hole diameter in the order as described above has no effect on flow rate regulation when the stem hole diameter is larger than others,
This is because even if the diameter of the vapor tap hole and the diameter of the pilot hole are large, if the hole diameter of the vapor tap is large, the above-mentioned breathing injection may not occur.
次に噴射装置の一部であるエアゾール用ボタンの穴径
は、0.25φmm〜0.4φmmの間のものを用いるがさらに内
容物の通路に例えば0.25φmm〜0.3φmmの流量抑制孔
(ミドルオリフィス)を設けることで噴射量を一層小さ
くすることができる。内容物にしめる液化ガスの割合が
少ないためにボタンとしては通常のメカニカルブレイク
アップ付のボタンを用いると良いが穴径として0.25φmm
未満は、前記したような作成上の無理があり、0.4φmm
を超えると噴射量が多くなり法規上の微燃性の要件を満
足しない。内容物は上記したような通路を通って耐圧容
器内から外部に噴射されるのであるが、ハウジングには
ベーパータップ穴と下穴とがありこの下穴は、ディップ
チューブに連通している。ディップチューブ内の上昇し
た液はハウジング内で内容液と液化ガス気相が混合さ
れ、ステム穴を通りミドルオリフィスを通ってボタンの
噴射孔から外部に噴射される。したがってこれらの通路
内に別の形で流量を抑えるために径少の部分を設けても
さしつかえない。Next, the hole diameter of the aerosol button, which is a part of the injection device, is used between 0.25φmm and 0.4φmm, and a flow control hole (middle orifice) of 0.25φmm to 0.3φmm is further provided in the passage of the contents. By providing such an arrangement, the injection amount can be further reduced. Since the ratio of liquefied gas contained in the contents is small, it is good to use a button with a normal mechanical breakup as the button, but the hole diameter is 0.25 φmm
Less than 0.4 mm
If it exceeds, the injection amount will increase, and the requirement for slight flammability in the regulation will not be satisfied. The contents are ejected from the inside of the pressure-resistant container to the outside through the passage as described above. The housing has a vapor tap hole and a pilot hole, and the pilot hole communicates with the dip tube. The liquid that has risen in the dip tube is mixed with the content liquid and the liquefied gas gas phase in the housing, and is injected to the outside from the injection hole of the button through the middle orifice through the stem hole. Therefore, a small diameter portion may be provided in these passages in order to suppress the flow rate in another way.
次に本発明の実施例を用いてさらに詳細に説明するが
本発明はかかる実施例にのみに限定されるものではな
い。Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
実施例1 忌避剤 つぎに示す組成のエアゾール組成物を調製した。Example 1 Repellent An aerosol composition having the following composition was prepared.
DEET(ディエチルトルアミド 吉富製薬(株)製) 7.9g 1,3ブチレングリコール 6.0g 99%ゲラニオール変性アルコール 20.0ml 精製水 35.8ml DME 30.0ml LPG(25℃で圧力が3.5g/cm2) 2.0ml (注)mlは、20℃の値である(以下、の実施例及び比較
例においても同様)。DEET (diethyltoluamide, manufactured by Yoshitomi Pharmaceutical Co., Ltd.) 7.9 g 1,3 butylene glycol 6.0 g 99% geraniol denatured alcohol 20.0 ml Purified water 35.8 ml DME 30.0 ml LPG (3.5 g / cm 2 pressure at 25 ° C.) 2.0 ml (Note) ml is a value at 20 ° C. (the same applies to the following Examples and Comparative Examples).
前記エアゾール組成物のエアゾール用耐圧容器への充
填は、まずDEET及び1,3ブチレングリコールを99%ゲラ
ニオール変性アルコールに溶解し、これに精製水をを加
えて原液を調製し、これをエアゾール用耐圧容器へ充填
し、ついで噴射剤としてのDME及びLPGとの混合物を圧入
することにより行う。なお、mlは20℃の値である(以下
同様)。ついで、このエアゾール用耐圧容器にステム穴
径0.3φmm、ベーパータップ径0.3mmφ、下穴径0.6φmm
でディップチューブ付のバルブを装填し、ついで、噴射
孔穴径0.3φmm、ミドリオリフィス径0.3φmmのボタンを
装着することにより、忌避剤用のエアゾール製品を得
た。To fill the aerosol pressure-resistant container with the aerosol composition, first, DEET and 1,3-butylene glycol are dissolved in 99% geraniol-denatured alcohol, and purified water is added thereto to prepare a stock solution. This is carried out by filling a container and then press-fitting a mixture with DME and LPG as a propellant. Here, ml is a value at 20 ° C. (the same applies hereinafter). Next, a stem hole diameter of 0.3 mm, a vapor tap diameter of 0.3 mm, and a pilot hole diameter of 0.6 mm
Then, a valve with a dip tube was loaded, and then a button having an injection hole hole diameter of 0.3 mm and a midori orifice diameter of 0.3 mm was attached to obtain an aerosol product for a repellent.
実施例2 制汗剤 つぎに示す組成のエアゾール組成物を調製した。Example 2 Antiperspirant An aerosol composition having the following composition was prepared.
アルミニウム クロールバイドロオキサイド 3.0g 1,3−ブチレングリコール 3.0g 95%ブルシン変性アルコール 39.0ml 精製水 29.0ml DME 24.0ml LPG(25℃で圧力が2.7kg/cm2) 2.0ml 前記エアゾール組成物のエアゾール用耐圧容器への充
填は、まずアルミニウム クロールバイドロオキサイド
及び1,3−ブチレングリコールを95%ブルシン変性アル
コールに溶解し、分散させ、これに精製水をを加えて原
液を調製し、これをエアゾール用耐圧容器へ充填し、つ
いで、このエアゾール用耐圧容器にステム穴径0.33φm
m、ベーパータップ径0.33φmm、下穴径0.64φmmでディ
ップチューブ付のバルブを装填し、ついで噴射剤として
のDME及びLPGとの混合物を圧入することにより行う。つ
いで、噴射孔穴径0.25φmm、ミドリオリフィス径0.3φm
mのボタンを装着することにより、制汗剤用のエアゾー
ル製品を得た。Aluminum Chloride Vide Oxide 3.0 g 1,3-butylene glycol 3.0 g 95% brucine denatured alcohol 39.0 ml Purified water 29.0 ml DME 24.0 ml LPG (pressure at 25 ° C. 2.7 kg / cm 2 ) 2.0 ml Aerosol of the aerosol composition First, aluminum chloride hydride and 1,3-butylene glycol are dissolved and dispersed in 95% brucine-denatured alcohol, and purified water is added to the solution to prepare a stock solution. The aerosol pressure-resistant container is then filled with a stem hole diameter of 0.33φm.
m, a valve with a dip tube having a vapor tap diameter of 0.33 φmm and a pilot hole diameter of 0.64 φmm, and then press-fitting a mixture with DME and LPG as a propellant. Next, injection hole hole diameter 0.25φmm, Midori orifice diameter 0.3φm
By attaching the m button, an aerosol product for an antiperspirant was obtained.
このエアゾール製品の噴射量は25℃で0.4g/秒であっ
た。また、微燃性の要件は爆発濃度0.28g/、火炎長22
cmであった。The spray rate of this aerosol product was 0.4 g / sec at 25 ° C. Also, the requirement for slight flammability is an explosion concentration of 0.28 g / flame length of 22
cm.
実施例3 ボディコロン つぎに示す組成のエアゾール組成物を調製した。Example 3 Body Colon An aerosol composition having the following composition was prepared.
香料 2 g L−メントール 0.2g グリセリン 5.0ml 99%ローズP変性アルコール 20.0ml 精製水 47.8ml DME 24.0ml LPG 1.0ml 前記エアゾール組成物のエアゾール用耐圧容器への充
填は、まず香料、L−メントール及びグリセリンを99%
ローズP変性アルコールに溶解し、これに精製水をを加
えて原液を調製し、これをエアゾール用耐圧容器へ充填
し、ついで、このエアゾール用耐圧容器にステム穴径0.
25φmm、ベーパータップ径0.3φmm、下穴径0.5φmmでデ
ィップチューブ付のバルブを装填し、ついで噴射剤とし
てのDME及びLPGとの混合物を圧入することにより行う。
ついで、噴射孔穴径0.3φmm、ミドリオリフィス径0.3φ
mmのボタンを装着することにより、ボディコロン用のエ
アゾール製品を得た。Perfume 2 g L-menthol 0.2 g Glycerin 5.0 ml 99% Rose P denatured alcohol 20.0 ml Purified water 47.8 ml DME 24.0 ml LPG 1.0 ml At first, the aerosol composition was filled into a pressure-resistant container for aerosol, firstly perfume, L-menthol and Glycerin 99%
Dissolved in Rose P denatured alcohol, and purified water was added thereto to prepare a stock solution, which was filled in a pressure resistant container for aerosol.
This is performed by loading a valve with a dip tube having a diameter of 25 mm, a diameter of 0.3 mm and a diameter of 0.5 mm, and then press-fitting a mixture of DME and LPG as a propellant.
Next, the injection hole diameter is 0.3φmm, and the midorifice diameter is 0.3φ
By attaching the mm button, an aerosol product for body colon was obtained.
このエアゾール製品の噴射量は25℃で0.2g/秒であっ
た。また、微燃性の要件は爆発濃度0.29g/、火炎長17
cmであった。The spray rate of this aerosol product was 0.2 g / sec at 25 ° C. Also, the requirement for slight flammability is an explosion concentration of 0.29 g / flame length of 17
cm.
実施例4 消炎鎮痛剤 カンフル 3.0g メントール 3.0g サリチル酸メチル 2.5g サリチル酸グリコール 1.5g プロピレングリコール 5.0g 99%未変性アルコール 20.0ml イソプロピルアルコール 5.0ml 精製水 30.0ml DME 27.0ml LPG(25℃で圧力が3.0kg/cm2) 3.0ml 前記エアゾール組成物のエアゾール用耐圧容器への充
填は、まずカンフル、メントール、サリチル酸メチル、
サリチル酸グリコール、ポリエチレングリコール及び香
料を99%未変性アルコールに溶解し、これに精製水をを
加えて原液を調製し、これをエアゾール用耐圧容器へ充
填し、ついで、このエアゾール用耐圧容器にステム穴径
0.3φmm、ベーパータップ穴径0.35φmm、下穴径0.55φm
mでディップチューブ付のバルブを装填し、ついで噴射
剤としてのDME及びLPGとの混合物を圧入することにより
行う。ついで、噴射孔穴径0.3φmm、ミドリオリフィス
径0.35φmmのボタンを装着することにより、消炎鎮痛剤
用のエアゾール製品を得た。Example 4 Anti-inflammatory analgesic Camphor 3.0 g Menthol 3.0 g Methyl salicylate 2.5 g Glycol salicylate 1.5 g Propylene glycol 5.0 g 99% native alcohol 20.0 ml Isopropyl alcohol 5.0 ml Purified water 30.0 ml DME 27.0 ml LPG (pressure 3.0 at 25 ° C.) kg / cm 2 ) 3.0 ml The above-mentioned aerosol composition was charged into a pressure-resistant container for aerosol at first by using camphor, menthol, methyl salicylate,
Dissolve glycolic acid salicylate, polyethylene glycol and perfume in 99% undenatured alcohol, add purified water to it to prepare a stock solution, fill it into a pressure-resistant container for aerosol, and then put a stem hole in the pressure-resistant container for aerosol. Diameter
0.3φmm, vapor tap hole diameter 0.35φmm, pilot hole diameter 0.55φm
The procedure is carried out by charging a valve with a dip tube at m and then injecting a mixture with DME and LPG as propellant. Then, an aerosol product for an anti-inflammatory analgesic was obtained by mounting a button having a hole diameter of the injection hole of 0.3 mm and a midorifice diameter of 0.35 mm.
比較例1 エアゾール組成物の成分として、1,3ブチレングリコ
ールを除いた以外は、実施例1と同様にして、忌避剤用
のエアゾール製品を得た。Comparative Example 1 An aerosol product for a repellent was obtained in the same manner as in Example 1 except that 1,3 butylene glycol was omitted as a component of the aerosol composition.
比較例2 エアゾール組成物の成分として、1,3ブチレングリコ
ールを除いた以外は、実施例2と同様にして、制汗剤用
のエアゾール製品を得た。Comparative Example 2 An aerosol product for an antiperspirant was obtained in the same manner as in Example 2 except that 1,3 butylene glycol was omitted as a component of the aerosol composition.
比較例3 エアゾール組成物の成分として、グリセリンを除いた
以外は、実施例3と同様にして、ボディコロン用のエア
ゾール製品を得た。Comparative Example 3 An aerosol product for a body colon was obtained in the same manner as in Example 3, except that glycerin was removed as a component of the aerosol composition.
比較例4 エアゾール組成物の成分として、プロピレングリコー
ルを除いた以外は、実施例4と同様にして、消炎鎮痛剤
用のエアゾール製品を得た。Comparative Example 4 An aerosol product for an anti-inflammatory analgesic was obtained in the same manner as in Example 4 except that propylene glycol was omitted as a component of the aerosol composition.
次に、先ず、前記実施例1及び比較例1について、次
の実験条件および評価方法によって、有効成分の保留時
間の実験を行った。Next, an experiment on the retention time of the active ingredient was conducted on Example 1 and Comparative Example 1 under the following experimental conditions and evaluation method.
このエアゾール製品の噴射量は25℃で0.3g/秒であっ
た。また、微燃性の要件は爆発濃度0.27g/、火炎長18
cmであった。上記エアゾール製品の忌避効果を下記のよ
うに調査した結果を表に示す。The spray rate of this aerosol product was 0.3 g / sec at 25 ° C. Also, the requirement for slight flammability is an explosion concentration of 0.27 g / flame length 18
cm. The results of an investigation of the repellent effect of the aerosol product as described below are shown in the table.
(有効成分の保留時間) 健康な成人男子5名の片方の前腕に15cmにわたり3秒
間、実施例1及び比較例1の各製品を噴霧する。(Reservation time of active ingredient) Each of the products of Example 1 and Comparative Example 1 is sprayed onto one of the forearms of five healthy adult men over 15 cm for 3 seconds.
ヒトスジシマカ未吸血力を50匹放した30×30×40cmの
ゲージを2ヶ用意し、所定時間経過後、前述のように忌
避剤を噴霧した両腕をそれぞれゲージ内に2分間入れ、
その間に吸血した蚊の数を測定した。結果を第1表に示
す。Prepare two 30 × 30 × 40 cm gauges releasing 50 Aedes albopictus unblood-sucking power, and after a lapse of a predetermined time, put both arms sprayed with the repellent as described above into the gauges for 2 minutes, respectively.
The number of mosquitoes sucked during that time was measured. The results are shown in Table 1.
なお、忌避剤を噴霧した皮膚のみが露出するように、
未噴射部分は、ビニール手袋でおおった。In addition, so that only the skin sprayed with the repellent is exposed,
The unsprayed part was covered with vinyl gloves.
さらに、前記実施例1〜4及び比較例1〜4につい
て、次の実験条件及び評価方法によって、皮膚上の脱
脂、霧の状態及び燃焼性の実験を行った。 Further, with respect to Examples 1 to 4 and Comparative Examples 1 to 4, experiments on degreasing on the skin, the state of fog, and flammability were performed under the following experimental conditions and evaluation methods.
このエアゾール製品の噴射量は25℃で0.4g/秒であっ
た。また、微燃性の要件は爆発濃度0.27g/、火炎長23
cmであった。The spray rate of this aerosol product was 0.4 g / sec at 25 ° C. Also, the requirement for slight flammability is an explosion concentration of 0.27 g / flame length of 23
cm.
(皮膚上脱脂) 健康な成人男子10名の片方の前腕に10cmにわたり1秒
間噴霧する。これを同一箇所に対して15分おきに4回噴
霧を繰り返し、1時間後皮膚の状態を目視及び指触にて
感応比較した。全員全く変化を認めないものを○、一部
皮膚のパサツキ間を訴えるものを△、過半数の人が皮膚
のパサツキ感を感じ、一部皮膚上の脱脂で白化を認める
ものを×とした。(Degreasing on the skin) Spray 10 cm over 1 cm on one forearm of 10 healthy adult males. This was sprayed four times at the same location every 15 minutes, and after 1 hour, the skin condition was visually and finger-sensitively compared. In all cases, no change was observed, and in some cases, the skin complained of skin pats. In the case of △, a majority of the people felt the skin pats and some of them showed whitening due to degreasing on the skin.
(霧の状態) 前腕に10cmの距離で噴霧した場合、細い粒子が少なく
均一に塗布できるものを○、粒子が荒らく部分的に集中
して付着するか、細かすぎて周囲に飛散するものが多い
ものを△とした。(Fog state) When sprayed on the forearm at a distance of 10 cm, those with few fine particles that can be applied uniformly are good, and those where the particles are rough and partially concentrated or adhere too finely and scatter around Many were marked as △.
(燃焼性) 通産省告示第557号の規定に基づき燃焼性試験を実施
した。前記規定における微燃性以上に合格するものを
○、合格しないものを×とした。(Flammability) A flammability test was conducted based on the provisions of Notification No. 557 of the Ministry of International Trade and Industry. Those that passed the above-mentioned flammability were defined as ○, and those that did not pass were ×.
実験の結果を第2表に示す。 Table 2 shows the results of the experiment.
〔発明の効果〕 本発明は、上記のように、法規上の微燃性の要件を満
足し、比較的荒い霧状で噴射の際周囲に飛散の少ない噴
霧状態を得ると共に、皮膚上に噴射した場合でもDMEの
急激な気化に伴う前記皮膚の傷害の危険性を防ぎ、か
つ、皮膚表面への有効成分の保留時間を長くすることが
可能である等の顕著な効果を奏するものである。 [Effects of the Invention] As described above, the present invention satisfies the requirements for legally low flammability, obtains a spray state with a relatively rough mist and little scattering around when spraying, and sprays on the skin Even in this case, there is a remarkable effect that the danger of skin damage due to rapid vaporization of DME can be prevented, and the retention time of the active ingredient on the skin surface can be extended.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 B65D 83/16 B65D 83/14 D 83/28 83/42 83/58 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code Agency reference number FI Technical display location B65D 83/16 B65D 83/14 D 83/28 83/42 83/58
Claims (2)
コールおよび/またはイソプロピルアルコール20〜60容
量%、ならびに、ジメチルエーテルを60〜95容量%含む
可燃性液化ガス11〜40容量%よりなる成分系に、全体容
量に対して有効成分0.1〜12重量%と多価アルコール0.1
〜10重量%とを添加して、均一な溶解相となるような一
液のエアゾール用組成物をエアゾール用耐圧容器に充填
し、単位時間当りの噴射量が25℃で0.1〜0.5g/秒となる
ようなエアゾール用噴射装置を上記耐圧容器に取り付け
たことを特徴とするエアゾール製品。1. A component comprising 30 to 60% by volume of water at 20 ° C., 20 to 60% by volume of ethyl alcohol and / or isopropyl alcohol, and 11 to 40% by volume of a flammable liquefied gas containing 60 to 95% by volume of dimethyl ether. In the system, 0.1 to 12% by weight of active ingredient and polyhydric alcohol 0.1
~ 10% by weight, and a one-part aerosol composition to form a uniform dissolving phase is filled into a pressure-resistant container for aerosol, and the injection amount per unit time is 0.1 to 0.5 g / sec at 25 ° C. An aerosol product characterized in that an aerosol injection device as described below is attached to the pressure-resistant container.
ロピレングリコール、スクワラン、グリセリンより選ば
れる1種又はそれらの混合物である請求項1記載のエア
ゾール製品。2. The aerosol product according to claim 1, wherein the polyhydric alcohol is one selected from butylene glycol, propylene glycol, squalane, and glycerin, or a mixture thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63181754A JP2729244B2 (en) | 1988-07-22 | 1988-07-22 | Aerosol products |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63181754A JP2729244B2 (en) | 1988-07-22 | 1988-07-22 | Aerosol products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0232190A JPH0232190A (en) | 1990-02-01 |
| JP2729244B2 true JP2729244B2 (en) | 1998-03-18 |
Family
ID=16106303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63181754A Expired - Fee Related JP2729244B2 (en) | 1988-07-22 | 1988-07-22 | Aerosol products |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2729244B2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT723948E (en) * | 1995-01-24 | 2003-07-31 | Defense Tech Corp America | LACRIMOGENEO CAPSAICINOIDE |
| DE19722196C1 (en) * | 1997-05-27 | 1998-10-22 | Karl Engelhard Fabrik Pharm Pr | Di:ethyl-meta-toluamide based insect repellent composition |
| US7344707B2 (en) | 2002-05-15 | 2008-03-18 | The Procter & Gamble Company | Low combustion aerosol products in plastic packages having a reduced fire hazard classification that subsequently reduces storage costs |
| MXPA06014712A (en) | 2004-06-17 | 2007-02-12 | Unilever Nv | Cosmetic sprays. |
| JP5071953B2 (en) * | 2005-08-31 | 2012-11-14 | 大日本除蟲菊株式会社 | Powdery pest repellent composition |
| JP2008143845A (en) * | 2006-12-11 | 2008-06-26 | Hoshienu Seiyaku Kk | Nasal drop composition and nasal drop spraying tool |
| JP5344333B2 (en) * | 2007-01-09 | 2013-11-20 | アース製薬株式会社 | Aerosol composition |
| JP6018438B2 (en) * | 2012-06-29 | 2016-11-02 | 株式会社ダイゾー | Dripping aerosol products |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54106082A (en) * | 1978-02-07 | 1979-08-20 | Toyo Eazooru Kougiyou Kk | Threeephasic aerosol product |
| JPS63137981A (en) * | 1986-11-28 | 1988-06-09 | Kanebo Ltd | Water-containing aerosol composition |
-
1988
- 1988-07-22 JP JP63181754A patent/JP2729244B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0232190A (en) | 1990-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5695743A (en) | Medicinal aerosol formulations | |
| US5439670A (en) | Medicinal aerosol formulations | |
| ES2077971T5 (en) | MEDICAL FORMULATIONS IN AEROSOL THAT INCLUDE SALBUTAMOL. | |
| US5776434A (en) | Medicinal aerosol formulations | |
| JP3558393B2 (en) | Foamable aerosol composition | |
| JP2729244B2 (en) | Aerosol products | |
| JP3038837B2 (en) | Aerosol for skin cooling | |
| Williams III et al. | Influence of formulation additives on the vapor pressure of hydrofluoroalkane propellants | |
| JP3199444B2 (en) | Pest control method | |
| JP2642738B2 (en) | Aerosol products for human body application | |
| JPS6254784A (en) | Aerosol composition | |
| JP2005047882A (en) | Aerosol composition | |
| JP2001335468A (en) | Aerosol anti-inflammatory analgesic composition | |
| JP2540536B2 (en) | Azol type external application agent | |
| JP2706668B2 (en) | Aerosol composition | |
| JPS6233115A (en) | Spray composition for coating human body | |
| JP2003313101A (en) | Aerosol compositions and aerosol products | |
| JPH04189365A (en) | Aerosol container | |
| JPS63141917A (en) | Aerosol composition for hair-tonic | |
| JP3439672B2 (en) | Method for producing aerosol composition | |
| JP2795354B2 (en) | Aerosol products for human body | |
| JP2004283670A (en) | High pressure aerosol products | |
| JP2898316B2 (en) | Eazole products for human body | |
| JP2634858B2 (en) | Fast-breaking foamed aerosol composition | |
| JP3934193B2 (en) | Pest repellent aerosol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |